Fig. 1: Outcome of 318 patients receiving donor lymphocyte infusion in complete hematological remission. | Bone Marrow Transplantation

Fig. 1: Outcome of 318 patients receiving donor lymphocyte infusion in complete hematological remission.

From: Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia

Fig. 1

NRM non-relapse mortality, CRI cumulative relapse incidence, LFS leukemia-free survival, OS overall survival. DLI was given as prophylaxis (red curves), as preemptive therapy for minimal residual disease (MRD) or molecular relapse (blue curves), or as preemptive therapy for mixed donor chimerism (green curves).

Back to article page